Lynparza (olaparib) tablets, 150mg (YJ code: 4291052F2023, standard: 150mg 1 tablet), manufactured by AstraZeneca, are a PARP inhibitor used to treat certain types of ovarian, breast, pancreatic, and prostate cancers, particularly those with BRCA mutations. It works by preventing cancer cells from repairing damaged DNA, leading to their destruction.
Lynparza tablets 150mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).
